N
ETNB

Natixis’s 89bio ETNB Stock Holding History

Natixis’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-99,000
Closed -$1.15M – 1048
2024
Q1 		$1.15M Buy
+99,000
New +$1.1M 0.01% 509

Other funds holding ETNB

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Natixis's ETNB Position: Q2 2024 in Review

Natixis sold out of 89bio (ETNB) in Q2 2024, closing a stake of 99,000 shares — an estimated $1.15M sold.

Natixis first reported a position in ETNB in Q1 2024 and held it in 1 quarter. The position peaked at $1.15M in Q1 2024. 145 funds tracked by Wall St. Rank hold ETNB as of Q2 2024.

  • Natixis reported no remaining 89bio position as of Q2 2024 after selling out during the quarter.
  • Natixis sold 99,000 89bio shares in Q2 2024, an estimated $1.15M.
  • Natixis first reported a position in 89bio in Q1 2024 and held it in 1 quarter.
  • Natixis's 89bio position peaked at $1.15M in Q1 2024.
  • 145 funds tracked by Wall St. Rank held 89bio as of Q2 2024.

Based on Natixis's 13F filing for Q2 2024, filed 13 Aug 2024.